Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY:RMD)

251.23 -1.64 (-0.65%)
Streaming Delayed Price Updated: 1:43 PM EDT, Mar 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
News headline image
3 Healthcare Stocks to Buy and Hold for the Next 10 Years ↗
Don't overthink it -- buy companies with excellent financials and a long runway for growth. 
Via The Motley Fool
News headline image
Stocks That Hit 52-Week Highs On Tuesday ↗
On Tuesday morning, 54 companies achieved new highs for the year. Noteworthy Mentions: The largest company by market cap to set a new 52-week high was Costco... 
Via Benzinga
Expert Ratings For ResMed ↗
Within the last quarter, ResMed (NYSE:RMD) has observed the f... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Monday ↗
On Monday morning, 20 companies achieved new highs for the year. Areas of Significance: The largest company by market cap to break to a new 52-week high was PepsiCo... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Friday ↗
During Friday's morning trading, 90 companies set new 52-week highs. Intriguing Points: Microsoft (NASDAQ:MSFT) was the largest firm on a market cap basis to... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021 ↗
Upgrades CL King upgraded the previous rating for Compass Minerals International Inc (NYSE: 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Monday ↗
SVB Leerink raised Natera, Inc. (NASDAQ:NTRA) pr... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:... 
Via Benzinga
Topics Product Recall
News headline image
Stocks That Hit 52-Week Highs On Thursday ↗
This morning 158 companies set new 52-week highs. Intriguing Points: NVIDIA (NASDAQ:NVDA) was the largest firm on a market cap basis to set a new 52-week high. The... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Friday ↗
Friday's morning session saw 39 companies set new 52-week highs. Areas of Significance: The largest company by market cap to set a new 52-week high was NVIDIA (... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Wednesday ↗
This morning 132 companies reached new 52-week highs. Noteworthy Mentions: The largest company by market cap to break to a new 52-week high was NVIDIA (NASDAQ:NVDA... 
Via Benzinga
News headline image
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ... 
Via Benzinga
News headline image
Why ResMed Stock Exploded Higher This Week ↗
A competitor's misfortune could be a big opportunity for the medical device giant. 
Via The Motley Fool
News headline image
5 Reasons Why ResMed Gets Downgrade From BofA Securities ↗
Although ResMed Inc’s (NYSE:RMD) long-term outlook is p... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Tuesday ↗
Tuesday's morning session saw 105 companies set new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2021 ↗
Upgrades According to Piper Sandler, the prior rating for First Bancorp (NASDAQ: 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Thursday ↗
Before 10 a.m. ET on Thursday, 145 companies set new 52-week highs. Noteworthy Highlights: The largest company by market cap to hit a new 52-week high was Microsoft... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 15) Apellis Pharmaceuticals,... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
News headline image
P/E Ratio Insights for ResMed ↗
In the current session, ResMed Inc. (NYSE:RMD) is trading at $232.81, after a 0.48% increase. Over the past month, the stock increased by 20.29%, and in the past... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Tuesday ↗
Raymond James raised Nutrien Ltd. (NYSE: NTR) price target from $75 to $82. Nutrien shares fell 1.1% to trade at $63.05 on Tuesday. Credit Suisse lifted the price target on... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Wednesday ↗
This morning 122 companies reached new 52-week highs. Interesting Facts: The largest company on a market cap basis to set a new 52-week high was Microsoft (NASDAQ:... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Tuesday ↗
Before 10 a.m. ET on Tuesday, 125 stocks hit new 52-week highs. Significant Points: The largest company by market cap to set a new 52-week high was Alphabet (NASDAQ... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Highs On Thursday ↗
This morning 94 companies set new 52-week highs. Things to Consider: NVIDIA (NASDAQ:NVDA) was the largest firm by market cap to set a new 52-week high. Deswell Industries... 
Via Benzinga
News headline image
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
Via Benzinga
News headline image
2 Stocks That Are Much More Likely Than AMC to Make You Rich ↗
Gambling can be fun, but growing sales and profits are what matter for long-term gains. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 21, 2021 ↗
Upgrades According to JP Morgan, the prior rating for ResMed Inc (NYSE:RMD) was changed from Neutral to Overweight. For the third quarter, ResMed had an EPS of $1.30,... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2021 ↗
Upgrades For CEVA Inc (NASDAQ:CEVA), Barclays upgraded the previous rating of Equal-Weight to Overweight. For the first quarter, CEVA had an EPS of $0.01, compared to year... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.